endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

News Briefing channel feed

Im­mu­nic’s stock falls on mul­ti­ple scle­ro­sis da­ta; En­tra­da’s lay­offs

Last month

Ab­b­Vie’s Rin­voq is ap­proved in gi­ant cell ar­teri­tis; Rel­ma­da shares blad­der can­cer da­ta

Last month

Bio­haven gets an up to $600M in­vest­ment; Prile­nia, Fer­rer make a deal in Eu­rope

Last month

Lil­ly asks EU reg­u­la­tor to re­vis­it Kisun­la; CHMP rec­om­mends PTC's PKU drug

Last month

Avidi­cure's $50M seed round; Flag­ship's new AI com­pa­ny that de­tects dis­ease

Last month

Ve­r­axa makes a SPAC deal; Il­lu­mi­na dis­clos­es lay­offs

Last month

Dana­her ex­pects about $350M in tar­iff costs; Alu­mis, Ace­lyrin ad­just deal terms

Last month

No­var­tis ter­mi­nates knee pain study; Telix re­ports brain tu­mor da­ta

Last month

Boehringer's bis­pe­cif­ic pact with Cue Bio­phar­ma; He­paRe­geniX rais­es €21.5M

Last month

Third Har­mon­ic to shut­ter; Fu­ture Pak once again tar­gets Ther­at­e­ch­nolo­gies

Last month

Ar­genx’s Vyv­gart Hytru­lo sy­ringe is ap­proved in the US; Opthea to cut 65% of staff

Last month

Idor­sia’s blood pres­sure pill no longer re­quires a REMS; Solu rais­es $41M

Last month

Rally­bio ends de­vel­op­ment in rare dis­or­der; Im­mu­ni­ty­Bio rais­es $75M

Last month

Lex­eo dis­clos­es new da­ta for heart drug; Spark Ther­a­peu­tics to lay off work­ers

Last month

Sarep­ta in­di­cates it's safe to con­tin­ue Ele­v­idys dos­ing in Eu­rope; Ep­silo­gen buys TigaTx

2 months ago

Moon­Lake dis­clos­es up to $500M in fi­nanc­ing; OSR’s deal with in­no­va­tion fund 

2 months ago

Roche says Ocre­vus failed Phase 3 study; Sanofi li­cens­es au­toim­mune as­set from Nurix

2 months ago

Praz­er Ther­a­peu­tics rais­es $20M; Caris­ma lets go of most staff

2 months ago

LifeM­ine’s re­struc­tur­ing; Eu­rope won’t re­new au­tho­riza­tion for PTC’s Duchenne drug

2 months ago

DBV’s fi­nanc­ing for peanut al­ler­gy patch; Ei­sai di­vests pro­ton pump in­hibitor in Chi­na

2 months ago

Nkar­ta to lay off 34% of staff; Savara’s debt fi­nanc­ing deal

2 months ago

Hu­ma­cyte to raise $50M; Acrivon to fo­cus on prex­as­ert­ib in en­dome­tri­al can­cer

2 months ago

Cas­sa­va ends work on Alzheimer's drug; Alu­mis gets $40M up­front from Kak­en

2 months ago

Sur­rozen rais­es $175M, to fo­cus on oph­thal­mol­o­gy; CBC Group has a new $1B fund

2 months ago
First page Previous page 12345 Next page Last page
A service from the Financial Times